Biotech news
Asia-Pacific
Merck has been granted its first CRISPR technology patent by the Australian Patent Office. 16 June 2017
Americas
The Patent Trial and Appeal Board is not a “death squad” for drug patents, according to a study conducted by Fitzpatrick, Cella, Harper & Scinto. 15 June 2017
Americas
The US Supreme Court’s decision in the Amgen and Sandoz clash, which was handed down yesterday, has sparked disagreement between lawyers on the consequences of the ruling. 13 June 2017
Americas
The US Supreme Court has ruled that biosimilar applicants may provide notice to the manufacturer before obtaining a licence from the Food and Drug Administration for their biosimilars. 12 June 2017
Americas
Coherus BioSciences has asked a court to dismiss patent infringement allegations brought against it by Amgen. 12 June 2017
Americas
Law firm Foley & Lardner has hired a new partner, Karen Mangasarian, to join its New York office. 9 June 2017
Americas
Two thirds of biotech claims challenged in inter partes reviews are directed to methods of treatment, said Brendan O’Malley, partner at Fitzpatrick Cella Harper & Scinto, at a recent industry conference. 8 June 2017
Pharma
UK-based law firm Appleyard Lees has appointed Barbara Fleck as a partner in its Cambridge office. 1 June 2017
Americas
The Procter & Gamble Company and biotech company Canfield Scientific have sued Quantificare, a company manufacturing imaging solutions for clinical trials and physicians, for patent infringement. 30 May 2017
Americas
Biogen has asked the US District Court for the Eastern District of California to dismiss a competition complaint filed by biotech company Ixchel Pharma. 26 May 2017